Glimepiride Tablet
Product Images NDC 43063-587

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 43063-587). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063587 Label (43063587)

43063587 Label (43063587)
This is the labeling information of Glimepiride tablets. The package contains 30 tablets of 4 mg each. It is important to keep it out of the reach of children. Dosage and storage instructions are provided in the package insert. The tablets contain Glimepiride USP 4mg and are marked with NDC code 43063-587-30, manufacturer's lot numbers, and expiration date of 03/2020. Side effects may occur and patients are advised to consult their doctors if necessary. The last section of the text includes illegible characters, making it not-available to provide any useful description.*
FDA Label Image

Structure (Glimepiride Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.